SANTHERA PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Dec 2013)
What this means for you
This application is over — abandoned 09 Dec 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77320652
- Mark type
- Design + words
- Filed
- 02 Nov 2007
- Published for opposition
- 16 Dec 2008
- Abandoned
- 09 Dec 2013
- Attorney of record
- Patrick J. Concannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of bone, endocrinological, circulatory, hormonal and rheumatic disorders; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gebrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; but not for use in the fields of onlcology or rheumatoid arthritis; reagents for medical use; biological preparations for medical purposes but not for use in the fields of onlcology or rheumatoid arthritis; diagnostic agents, preparations and substances for medical purposes
- Class 009 — Scientific and electric apparatus: Scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computer hardware and software, for use with medical patient monitoring equipment, for measuring, receiving, processing, transmitting and displaying data; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computers, gamma cameras, collimators, aperture plates and computer software, all sold together as a unit for use in measuring the physical and mental condition of individuals affected by ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use
- Class 010 — Medical apparatus: Surgical and medical apparatus and instruments for use in general surgery
- Class 016 — Paper goods and printed matter: Printed informational cards in the field of pharmaceuticals; printed publications, namely, newsletters, case studies, and white papers in the fields of pharmaceuticals, central nervous system-related conditions, ophthalmological diseases, and neuromuscular diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; chemical analysis for the pharmaceutical industry; scientific research and development; scientific research, namely, conducting clinical trials; providing scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Hygienic and beauty care for human beings or animals, namely, providing health, medical and pharmaceutical information, consultancy and advisory services
Owner
- Santhera Pharmaceuticals Holding AG, Liestal, CH
- Santhera Pharmaceuticals Holding AG, Liestal, CH
Prior registrations
Prosecution history
- 09 Dec 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 09 Dec 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Sept 2013 — ASSIGNED TO EXAMINER
- 25 May 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2013 — SOU EXTENSION 5 GRANTED
- 29 Apr 2013 — SOU EXTENSION 5 FILED
- 24 May 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Apr 2013 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2012 — SOU EXTENSION 4 GRANTED
- 25 Oct 2012 — SOU EXTENSION 4 FILED
- 25 Oct 2012 — SOU TEAS EXTENSION RECEIVED
- 03 May 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2012 — SOU EXTENSION 3 GRANTED
- 25 Apr 2012 — SOU EXTENSION 3 FILED